For citations:
Bukharkin B.V., Kalinin S.A. Docetaxel in the treatment of hormone-resistant prostate cancer. Cancer Urology. 2007;3(1):50-52. (In Russ.) https://doi.org/10.17650/1726-9776-2007-3-1-50-52
Fullscreen
Popular articles
Vol 12, No 1 (2016)
Vol 10, No 4 (2014)
Vol 14, No 2 (2018)
Vol 13, No 1 (2017)
Vol 15, No 1 (2019)
About the Authors
Keywords
biochemical recurrence
bladder cancer
chemotherapy
docetaxel
hormone therapy
immunotherapy
kidney cancer
magnetic resonance imaging
metastatic renal cell carcinoma
overall survival
partial nephrectomy
prostate cancer
prostate-specific antigen
radical cystectomy
radical prostatectomy
recurrence
renal cancer
renal cell carcinoma
surgical treatment
survival
targeted therapy
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required) “ABV-press” publishing house
Research Institute of Carcinogenesis
Floor 3, 24 Kashirskoe Shosse, Build. 15,
Moscow 115478, Russian Federation
tel. +7 (499) 929-96-19,
E-mail: abv@abvpress.ru
